LeonaBio, Inc. (LONA)
4.62
-0.15
(-3.14%)
USD |
NASDAQ |
Nov 04, 14:58
LeonaBio Market Cap : 43.53M for Nov. 4, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 03, 2026 | 44.94M |
| November 02, 2026 | 44.56M |
| October 30, 2026 | 46.54M |
| October 29, 2026 | 46.26M |
| October 28, 2026 | 46.73M |
| October 27, 2026 | 46.07M |
| October 26, 2026 | 44.85M |
| October 23, 2026 | 45.60M |
| October 22, 2026 | 46.83M |
| October 21, 2026 | 53.42M |
| October 20, 2026 | 49.65M |
| October 19, 2026 | 47.58M |
| October 16, 2026 | 48.99M |
| October 15, 2026 | 49.84M |
| October 14, 2026 | 50.78M |
| October 13, 2026 | 60.58M |
| October 12, 2026 | 58.08M |
| October 09, 2026 | 54.17M |
| October 08, 2026 | 54.17M |
| October 07, 2026 | 54.93M |
| October 06, 2026 | 54.17M |
| October 05, 2026 | 52.57M |
| October 02, 2026 | 45.41M |
| October 01, 2026 | 41.27M |
| September 30, 2026 | 33.64M |
| Date | Value |
|---|---|
| September 29, 2026 | 33.07M |
| September 28, 2026 | 27.04M |
| September 25, 2026 | 30.62M |
| September 24, 2026 | 47.01M |
| September 23, 2026 | 55.49M |
| September 22, 2026 | 57.00M |
| September 21, 2026 | 59.64M |
| September 18, 2026 | 63.97M |
| September 17, 2026 | 65.48M |
| September 16, 2026 | 63.97M |
| September 15, 2026 | 68.21M |
| September 14, 2026 | 70.38M |
| September 11, 2026 | 65.20M |
| September 10, 2026 | 64.63M |
| September 09, 2026 | 66.33M |
| September 08, 2026 | 75.56M |
| September 04, 2026 | 71.23M |
| September 03, 2026 | 72.55M |
| September 02, 2026 | 72.26M |
| September 01, 2026 | 71.51M |
| August 31, 2026 | 74.62M |
| August 28, 2026 | 74.81M |
| August 27, 2026 | 74.34M |
| August 26, 2026 | 73.58M |
| August 25, 2026 | 75.47M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cocrystal Pharma, Inc. | 14.06M |
| CNBX Pharmaceuticals, Inc. | 0.1919M |
| Arvinas, Inc. | 481.91M |
| Fulcrum Therapeutics, Inc. | 286.83M |
| Definium Therapeutics, Inc. | 4.378B |
Market Cap Related Metrics
| PEG Ratio | -0.0008 |
| Price to Book Value | 1.296 |
| Price | 4.62 |
| Earnings Yield | -500.2% |
| PEGY Ratio | -0.0008 |